HUE068886T2 - (1R,3S)-3-(5-Ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentán-karbonsav kokristályai - Google Patents

(1R,3S)-3-(5-Ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentán-karbonsav kokristályai

Info

Publication number
HUE068886T2
HUE068886T2 HUE21710531A HUE21710531A HUE068886T2 HU E068886 T2 HUE068886 T2 HU E068886T2 HU E21710531 A HUE21710531 A HU E21710531A HU E21710531 A HUE21710531 A HU E21710531A HU E068886 T2 HUE068886 T2 HU E068886T2
Authority
HU
Hungary
Prior art keywords
cocrystals
ylcarbamoyl
thiazol
cyano
phenyl
Prior art date
Application number
HUE21710531A
Other languages
English (en)
Hungarian (hu)
Inventor
Laria Julio Castro Palomino
Gomez Juan Camacho
Original Assignee
Palobiofarma Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palobiofarma Sl filed Critical Palobiofarma Sl
Publication of HUE068886T2 publication Critical patent/HUE068886T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/02Salts; Complexes; Addition compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE21710531A 2020-03-16 2021-03-15 (1R,3S)-3-(5-Ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentán-karbonsav kokristályai HUE068886T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20382194.7A EP3882240A1 (en) 2020-03-16 2020-03-16 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid

Publications (1)

Publication Number Publication Date
HUE068886T2 true HUE068886T2 (hu) 2025-02-28

Family

ID=69953938

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE21710531A HUE068886T2 (hu) 2020-03-16 2021-03-15 (1R,3S)-3-(5-Ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentán-karbonsav kokristályai

Country Status (21)

Country Link
US (1) US12384754B2 (https=)
EP (2) EP3882240A1 (https=)
JP (1) JP7779846B2 (https=)
KR (1) KR20220154791A (https=)
CN (1) CN115298169B (https=)
AU (1) AU2021237686B2 (https=)
BR (1) BR112022018449A2 (https=)
CA (1) CA3171894C (https=)
DK (1) DK4121419T3 (https=)
ES (1) ES3002084T3 (https=)
FI (1) FI4121419T3 (https=)
HR (1) HRP20241515T1 (https=)
HU (1) HUE068886T2 (https=)
LT (1) LT4121419T (https=)
MX (1) MX2022011530A (https=)
PL (1) PL4121419T3 (https=)
PT (1) PT4121419T (https=)
RS (1) RS66214B1 (https=)
SI (1) SI4121419T1 (https=)
WO (1) WO2021185748A1 (https=)
ZA (1) ZA202211247B (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2331220B1 (es) 2007-10-02 2010-09-23 Palobiofarma, S.L. Nuevos compuestos como antagonistas de los receptores a1 de adenosina.
US8779146B2 (en) 2010-04-28 2014-07-15 Nuformix Limited Cilostazol cocrystals and compositions
LT3592734T (lt) 2017-03-06 2021-07-26 Palobiofarma, S.L. (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksirūgšties amino druska

Also Published As

Publication number Publication date
ES3002084T3 (en) 2025-03-06
JP7779846B2 (ja) 2025-12-03
KR20220154791A (ko) 2022-11-22
MX2022011530A (es) 2022-10-13
EP4121419A1 (en) 2023-01-25
CN115298169A (zh) 2022-11-04
FI4121419T3 (fi) 2024-11-04
US12384754B2 (en) 2025-08-12
LT4121419T (lt) 2024-11-25
CA3171894C (en) 2025-03-11
EP3882240A1 (en) 2021-09-22
WO2021185748A1 (en) 2021-09-23
CN115298169B (zh) 2024-11-19
US20230183195A1 (en) 2023-06-15
DK4121419T3 (da) 2024-10-28
ZA202211247B (en) 2023-12-20
AU2021237686A1 (en) 2022-10-06
BR112022018449A2 (pt) 2022-11-01
AU2021237686B2 (en) 2026-04-09
HRP20241515T1 (hr) 2025-01-03
PL4121419T3 (pl) 2025-02-17
CA3171894A1 (en) 2021-09-23
EP4121419B1 (en) 2024-08-14
PT4121419T (pt) 2024-11-18
SI4121419T1 (sl) 2025-02-28
RS66214B1 (sr) 2024-12-31
JP2023517722A (ja) 2023-04-26

Similar Documents

Publication Publication Date Title
EP4003950A4 (en) C4 ALKANOIC ACID RECYCLING CONTENT
EP3956783A4 (en) MONETIZATION OF ANIMAL DATA
WO2016012965A3 (en) Substituted phenyl alkanoic acid compounds as gpr120 agonists and uses thereof
EP3891620A4 (en) TRANSACTIONAL STREAMING OF CHANGE TRACKING DATA
WO2017042828A3 (en) Process for the preparation of selexipag
EP4212503A4 (en) FLUORINATED CARBOXYLIC ACID SALT COMPOUND
ZA202211247B (en) Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid
HK40087530A (en) Cocrystals of(1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid
EP3987772A4 (en) SHARED RESOURCE FOR TRANSFORMING DATA
PL3592734T3 (pl) Sól aminowa kwasu (1r,3s)-3-(5-cyano-4-fenylo-1,3-tiazol- 2-ilokarbamoilo)cyklopentanokarboksylowego
EP4059944A4 (en) METHOD FOR PREPARING AN OLIGONUCLICE ACID COMPOUND
EP4059943A4 (en) METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND
SI3980003T1 (sl) Izopropil ester (((1R,2S,5R)-2-izopropil-5-metil-cikloheksankarbonil)- amino)-ocetne kisline za zdravljenje kroničnega kašlja
EP4064827A4 (en) TRANSFORMATION PROCESS
EP4083224A4 (en) METHOD FOR ASYMMETRIC TARGET NUCLEIC ACID AMPLIFICATION
EP3976110A4 (en) DRUG TARGET OF IDIOPATHIC PULMONARY FIBROSIS
IL290505A (en) Process for the preparation of carboxylic acid derivatives of 3-bromo-4,5-dihydro-1h-pyrazoles
EP3093281A4 (en) Alkali metal salt of perfluoro(vinyloxy polyether) carboxylic acid, and method for producing same
HK40128362A (en) Metap2 inhibitors for the treatment of pulmonary fibrosis
CA3264343A1 (en) METAP2 INHIBITORS FOR THE TREATMENT OF PULMONARY FIBROSIS
EP4319743A4 (en) UPADACITINIB CO-CRYSTALS
HK40116338A (en) Crystalline forms of n-((1r,3s)-3-(4-acetylpiperazin-1-yl)cyclohexyl)-4-fluoro-7-methyl-1h-indole-2-carboxamide
CA3287358A1 (en) Formation of co-crystals
HK40073337A (en) Glycolate oxidase inhibitors for the treatment of disease
HK40058379A (en) Methods of promoting remyelination